Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-26-035218
Filing Date
2026-07-29
Accepted
2026-07-29 17:00:00
Documents
1
Period of Report
2026-07-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 2195
  Complete submission text file 0001493152-26-035218.txt   3627
Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Issuer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12 SHAUL HAMELECH STREET KIRYAT ONO Israel 00000
Business Address
Teleman Dan Benjamin (Reporting) CIK: 0002122500 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42796 | Film No.: 261218692